BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 23748175)

  • 1. Alterations in expression pattern of splicing factors in epithelial ovarian cancer and its clinical impact.
    Iborra S; Hirschfeld M; Jaeger M; Zur Hausen A; Braicu I; Sehouli J; Gitsch G; Stickeler E
    Int J Gynecol Cancer; 2013 Jul; 23(6):990-6. PubMed ID: 23748175
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overexpression of salusin-β is associated with poor prognosis in ovarian cancer.
    Zhang Q; Chen WM; Zhang XX; Zhang HX; Wang HC; Zheng FY; Zhu FF
    Oncol Rep; 2017 Mar; 37(3):1826-1832. PubMed ID: 28184918
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Profiling cancer gene mutations in longitudinal epithelial ovarian cancer biopsies by targeted next-generation sequencing: a retrospective study.
    Beltrame L; Di Marino M; Fruscio R; Calura E; Chapman B; Clivio L; Sina F; Mele C; Iatropoulos P; Grassi T; Fotia V; Romualdi C; Martini P; Noris M; Paracchini L; Craparotta I; Petrillo M; Milani R; Perego P; Ravaggi A; Zambelli A; Ronchetti E; D'Incalci M; Marchini S
    Ann Oncol; 2015 Jul; 26(7):1363-71. PubMed ID: 25846551
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical significance of galectin-7 in epithelial ovarian cancer.
    Kim HJ; Jeon HK; Lee JK; Sung CO; Do IG; Choi CH; Kim TJ; Kim BG; Bae DS; Lee JW
    Anticancer Res; 2013 Apr; 33(4):1555-61. PubMed ID: 23564797
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pooled analysis of the prognostic relevance of disseminated tumor cells in the bone marrow of patients with ovarian cancer.
    Fehm T; Banys M; Rack B; Janni W; Marth C; Blassl C; Hartkopf A; Trope C; Kimmig R; Krawczyk N; Wallwiener D; Wimberger P; Kasimir-Bauer S
    Int J Gynecol Cancer; 2013 Jun; 23(5):839-45. PubMed ID: 23694981
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential transcriptional and protein expression of thyroid-stimulating hormone receptor in ovarian carcinomas.
    Gyftaki R; Liacos C; Politi E; Liontos M; Saltiki K; Papageorgiou T; Thomakos N; Haidopoulos D; Rodolakis A; Alevizaki M; Bamias A; Dimopoulos A
    Int J Gynecol Cancer; 2014 Jun; 24(5):851-6. PubMed ID: 24844218
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of prognostic factors on survival rates in patients with ovarian carcinoma.
    Arikan SK; Kasap B; Yetimalar H; Yildiz A; Sakarya DK; Tatar S
    Asian Pac J Cancer Prev; 2014; 15(15):6087-94. PubMed ID: 25124578
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development and validation of a microRNA-based signature (MiROvaR) to predict early relapse or progression of epithelial ovarian cancer: a cohort study.
    Bagnoli M; Canevari S; Califano D; Losito S; Maio MD; Raspagliesi F; Carcangiu ML; Toffoli G; Cecchin E; Sorio R; Canzonieri V; Russo D; Scognamiglio G; Chiappetta G; Baldassarre G; Lorusso D; Scambia G; Zannoni GF; Savarese A; Carosi M; Scollo P; Breda E; Murgia V; Perrone F; Pignata S; De Cecco L; Mezzanzanica D;
    Lancet Oncol; 2016 Aug; 17(8):1137-1146. PubMed ID: 27402147
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transketolase is upregulated in metastatic peritoneal implants and promotes ovarian cancer cell proliferation.
    Ricciardelli C; Lokman NA; Cheruvu S; Tan IA; Ween MP; Pyragius CE; Ruszkiewicz A; Hoffmann P; Oehler MK
    Clin Exp Metastasis; 2015 Jun; 32(5):441-55. PubMed ID: 25895698
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sterol regulatory element-binding protein 1 is required for ovarian tumor growth.
    Nie LY; Lu QT; Li WH; Yang N; Dongol S; Zhang X; Jiang J
    Oncol Rep; 2013 Sep; 30(3):1346-54. PubMed ID: 23818099
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ELF5 in epithelial ovarian carcinoma tissues and biological behavior in ovarian carcinoma cells.
    Yan H; Qiu L; Xie X; Yang H; Liu Y; Lin X; Huang H
    Oncol Rep; 2017 Mar; 37(3):1412-1418. PubMed ID: 28184931
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcome in serous ovarian cancer is not associated with LATS expression.
    Montavon C; Stricker GR; Schoetzau A; Heinzelmann-Schwarz V; Jacob F; Fedier A
    J Cancer Res Clin Oncol; 2019 Nov; 145(11):2737-2749. PubMed ID: 31586262
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ATAD2 is highly expressed in ovarian carcinomas and indicates poor prognosis.
    Wan WN; Zhang YX; Wang XM; Liu YJ; Zhang YQ; Que YH; Zhao WJ
    Asian Pac J Cancer Prev; 2014; 15(6):2777-83. PubMed ID: 24761900
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epithelial Ovarian Cancer Metastatic to the Central Nervous System and a Family History Concerning for Hereditary Breast and Ovarian Cancer--A Potential Relationship.
    Jernigan AM; Mahdi H; Rose PG
    Int J Gynecol Cancer; 2015 Sep; 25(7):1232-8. PubMed ID: 26067864
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HSP60 predicts survival in advanced serous ovarian cancer.
    Hjerpe E; Egyhazi S; Carlson J; Stolt MF; Schedvins K; Johansson H; Shoshan M; Avall-Lundqvist E
    Int J Gynecol Cancer; 2013 Mar; 23(3):448-55. PubMed ID: 23429486
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of tRNA methyltransferase NSUN2/IGF-II molecular signature with ovarian cancer survival.
    Yang JC; Risch E; Zhang M; Huang C; Huang H; Lu L
    Future Oncol; 2017 Sep; 13(22):1981-1990. PubMed ID: 28829218
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Musashi-2 is a novel regulator of paclitaxel sensitivity in ovarian cancer cells.
    Lee J; An S; Choi YM; Lee J; Ahn KJ; Lee JH; Kim TJ; An IS; Bae S
    Int J Oncol; 2016 Nov; 49(5):1945-1952. PubMed ID: 27600258
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intraoperative Diagnosis Support Tool for Serous Ovarian Tumors Based on Microarray Data Using Multicategory Machine Learning.
    Park JS; Choi SB; Kim HJ; Cho NH; Kim SW; Kim YT; Nam EJ; Chung JW; Kim DW
    Int J Gynecol Cancer; 2016 Jan; 26(1):104-13. PubMed ID: 26512784
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TEX19 promotes ovarian carcinoma progression and is a potential target for epitope vaccine immunotherapy.
    Xu Z; Tang H; Zhang T; Sun M; Han Q; Xu J; Wei M; Yu Z
    Life Sci; 2020 Jan; 241():117171. PubMed ID: 31843525
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Restaging and Survival Analysis of 4036 Ovarian Cancer Patients According to the 2013 FIGO Classification for Ovarian, Fallopian Tube, and Primary Peritoneal Cancer.
    Rosendahl M; Høgdall CK; Mosgaard BJ
    Int J Gynecol Cancer; 2016 May; 26(4):680-7. PubMed ID: 26937751
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.